Conditions: Gastric Adenocarcinoma; Esophageal Squamous Cell Carcinoma; Nasopharyngeal Carcinoma; Head and Neck Squamous Cell Carcinoma
Interventions: Biological: 3 mg/kg humanized anti-PD-1 mAb; Biological: 10 mg/kg humanized anti-PD-1 mAb
Sponsor: Shanghai Junshi Bioscience Co.,Ltd.
Not yet recruiting - verified September 2016
http://ift.tt/2dAA0KM
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου